New kidney disease drug begins early safety testing
Disease control
Recruiting now
This early-stage study aims to find out if a new drug called IGT-303 is safe for people. It will test single and multiple doses given as shots under the skin or into a vein. Researchers will compare the drug to a placebo in about 94 healthy volunteers and people with chronic kidn…
Phase: PHASE1, PHASE2 • Sponsor: Ingenia Therapeutics INC • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC